BioSpace News Archive

RES announced today the acquisition of Applied Ecological Services (AES), one of the nation’s longest-standing ecological restoration firms and a leader in applying the science of ecology to land-use decisions.

Culturally-Centric Life Science Company aggressively accelerates the development of the lead platform StarSense and expand the development of a Rubix LS owned clinical trial site for launching clinical trials.

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today announced sponsorship from the Duchenne Research Fund for an award totaling over $100,000.

Nanomix, a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that the company has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration (FDA) for the eLab® COVID-19 rapid antigen test.

With rising prevalence of diabetes around the world, several awareness campaigns and government initiatives regarding preventive care of diabetes are being undertaken worldwide.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced that Revitope Oncology is extending its collaboration to develop a systems pharmacology model for Revitope’s dual antigen targeting TwoGATE™ platform for solid tumor indications.

Pregna International Ltd - a leading women’s healthcare company – has partnered with Dr. Thomas Burke’s Vayu Global Health Initiative to introduce an economical solution to Post-Partum Haemorrhage – one of the leading causes of maternal mortality.

Labcorp (NYSE: LH), a leading global life sciences company, today announced the appointments of Prasanth Reddy, MD, MPH, and Robert Phillips, PhD, to its oncology team, advancing Labcorp’s leadership position and capabilities in cancer diagnosis, treatment, and drug development.

The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.

One of the recent developments in the self-monitoring blood glucose devices market comprises a study conducted by researchers from the University of Texas Health Science Center, San Antonio.